Kaushik Lakkaraju

Senior Director, Business Development Pharmaceuticals at Fresenius Kabi - Bad Homburg, Hessen, DE

Kaushik Lakkaraju's Colleagues at Fresenius Kabi
Robert Jacobus

Regional Director, Quality Control

Contact Robert Jacobus

Jean Allaume

Sr Director, Expansion project

Contact Jean Allaume

Mary Johnson

Senior Director, Regional Training & Development

Contact Mary Johnson

Kurt Attermeier

Director of Combination Products Platform

Contact Kurt Attermeier

Loretta Dorn

Director Of Nursing Consultants

Contact Loretta Dorn

Krishna Gurupalli

Director, Enterprise Applications

Contact Krishna Gurupalli

Axel Stover

Director, Scientific Affairs

Contact Axel Stover

View All Kaushik Lakkaraju's Colleagues
Kaushik Lakkaraju's Contact Details
HQ
(496) 172-6860
Location
Company
Fresenius Kabi
Kaushik Lakkaraju's Company Details
Fresenius Kabi logo, Fresenius Kabi contact details

Fresenius Kabi

Bad Homburg, Hessen, DE • 22278 Employees
Major Drugs

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With more than 43,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of almost 450 million patients annually. With Vision 2026, as part of the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale. For more information, please visit www.fresenius-kabi.com. Imprint: https://www.fresenius-kabi.com/imprint

Global Healthcare Medical Technologies Biosimilars Clinical Nutrition Medical Devices Oncology Autoimmune Disease
Details about Fresenius Kabi
Frequently Asked Questions about Kaushik Lakkaraju
Kaushik Lakkaraju currently works for Fresenius Kabi.
Kaushik Lakkaraju's role at Fresenius Kabi is Senior Director, Business Development Pharmaceuticals.
Kaushik Lakkaraju's email address is ***@fresenius-kabi.com. To view Kaushik Lakkaraju's full email address, please signup to ConnectPlex.
Kaushik Lakkaraju works in the Major Drugs industry.
Kaushik Lakkaraju's colleagues at Fresenius Kabi are Robert Jacobus, Jean Allaume, Mary Johnson, Kurt Attermeier, Loretta Dorn, Krishna Gurupalli, Axel Stover and others.
Kaushik Lakkaraju's phone number is (496) 172-6860
See more information about Kaushik Lakkaraju